Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells
Abstract Background Adrenocortical carcinomas (ACC) are rare and aggressive cancer. Our previous study has revealed that the transcription factor 21, TCF21, is downregulated in ACC and regulates steroidogenic factor 1 (SF-1) binding to the SF-1 E-box promoter. In addition, it could be found that TCF...
Main Authors: | Jean Lucas Kremer, Thais Barabba Auricino, Bárbara dos Santos Passaia, Claudimara Ferini Pacicco Lotfi |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2021-07-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-021-00417-6 |
Similar Items
-
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
by: Monica Malheiros França, et al. -
TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors
by: Barbara dos Santos Passaia, et al.
Published: (2018-02-01) -
The human adrenal cortex: growth control and disorders
by: Claudimara Ferini Pacicco Lotfi, et al.
Published: (2018-09-01) -
TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration
by: Saskia L. Gooskens, et al.
Published: (2018-02-01) -
The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
by: Elaine Silveira, et al.
Published: (2018-03-01)